Inulin 관련 Gut Dysbiosis
DIncreases Bifidobacterium counts (1-2 log). Whether this diversity improvement translates to clinical outcomes is unclear.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'gutcited.com';
const params = 'ingredient\u003Dinulin\u0026condition\u003Dgut\u002Ddysbiosis';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
D
결론
Increases Bifidobacterium counts (1-2 log). Whether this diversity improvement translates to clinical outcomes is unclear.
Key Study Findings
Review
Interplay of probiotics, prebiotics, synbiotics and postbiotics: a review of their therapeutic potential for gastrointestinal …
Dose: None
vs: None
Outcome: None
효과: None
None
대상 집단: review of prebiotics, probiotics, synbiotics, postbiotics for gastrointestinal inflammation
Review
Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions.
Dose: None
vs: None
Outcome: gut health outcomes including microbiota modulation and SCFA …
효과: None
None
대상 집단: healthy individuals, children, elderly, and those with constipation, metabolic syndrome, or dysbiosis
Review
The role of traditional Chinese medicine in modulating gut microbiota to alleviating insulin resistance in …
Dose: None
vs: None
Outcome: PCOS insulin resistance via gut microbiota
효과: None
None
대상 집단: Women with PCOS and insulin resistance
Review
Microbiome Modulation in Pediatric Leukemia: Impact on Graft-Versus-Host Disease and Treatment Outcomes: A Narrative Review.
Dose: None
vs: None
Outcome: None
효과: None
None
대상 집단: None
In Vitro
Orchestrating Gut Disorders by Oral Delivery of a Living-Synthetic Hybrid Hydrogel.
Dose: None
vs: UC murine model
Outcome: UC pathological microenvironment amelioration
효과: None
None
대상 집단: UC murine model
In Vitro
2 weeks
Inulin alleviates chronic ketamine-induced impairments in memory and prepulse inhibition by regulating the gut microbiota, …
Dose: None
vs: Chronic ketamine (14 days) mouse model
Outcome: Memory and PPI improvement
효과: None
None
대상 집단: Chronic ketamine-exposed mice
Key Statistics
3
연구
200
참여자
↑
Positive
D
등급
Referenced Papers
Nutrients
2026
1 인용
Food research international …
2026
Children (Basel, Switzerland)
2025
18 인용
ACS nano
2025
10 인용
International journal of …
2025
8 인용
Environmental pollution (Barking, …
2025
6 인용
Nature metabolism
2025
6 인용
Free radical biology …
2025
5 인용
Small (Weinheim an …
2025
4 인용
Frontiers in pharmacology
2025
4 인용
BMJ open
2025
2 인용
Clinical nutrition ESPEN
2025
2 인용
Scientific reports
2025
1 인용
Cell reports
2025
1 인용
BMC gastroenterology
2025
1 인용
Frontiers in nutrition
2025
ACS nano
2025
Brain, behavior, and …
2025
Gastroenterology
2024
61 인용
Nature communications
2024
60 인용
International journal of …
2024
33 인용
Gut microbes
2024
32 인용
Nature materials
2024
28 인용
Phytomedicine : international …
2024
22 인용
Nutrients
2024
20 인용
Gut microbes
2024
20 인용
Romanian journal of …
2024
20 인용
Foods (Basel, Switzerland)
2024
11 인용
Journal of agricultural …
2024
10 인용
Przeglad gastroenterologiczny
2024
7 인용
Nutrients
2024
7 인용
mBio
2024
5 인용
Frontiers in gastroenterology …
2024
4 인용
World journal of …
2023
215 인용
Nutrients
2023
53 인용
The British journal …
2023
22 인용
Animals : an …
2023
16 인용
Gut microbes
2023
15 인용
Cell transplantation
2023
14 인용
Scientific reports
2023
14 인용
Nutrients
2023
9 인용
Nutrients
2022
19 인용
Journal of cellular …
2022
15 인용
Frontiers in microbiomes
2022
9 인용
Translational pediatrics
2021
11 인용
The effects of inulin on gut microbial composition: a systematic review of evidence from human studies.
Meta-Analysis
European journal of …
2020
190 인용
Progress in molecular …
2020
58 인용
Environmental pollution (Barking, …
2020
22 인용
Current pharmaceutical design
2020
17 인용
Endocrine journal
2019
88 인용
Journal of ethnopharmacology
2019
83 인용
Nutrients
2019
51 인용
Cell
2018
443 인용
Frontiers in microbiology
2018
73 인용
Cell host & …
2017
399 인용
Zhongguo Zhong yao …
2017
8 인용
Digestion
2016
522 인용
Phytotherapy research : …
2013
80 인용
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
일반적으로 사용되는 용량
- general:
- 5-10 g/day
- constipationsupport:
- 12 g/day for 4 weeks
- prebioticmaintenance:
- 5-8 g/day
상한량: Well-tolerated up to 20 g/day; start low and increase gradually
연구에서 사용된 용량
| 용량 | 기간 | 효과 | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | 2 weeks | Positive | -- |
| None | -- | Positive | -- |
| None | 26 weeks | Mixed | 144 |
권장 복용 시간: With meals; divide doses throughout the day to minimize gas
Safety & Side Effects
보고된 부작용
- ⚠ Gas and bloating (common at higher doses; start with 3-5 g/day and titrate up)
- ⚠ Abdominal cramping
- ⚠ Flatulence
- ⚠ Loose stools at very high doses
알려진 상호작용
- ● May enhance absorption of calcium and magnesium (beneficial interaction)
- ● Blood sugar-lowering medications (inulin may modestly reduce blood glucose)
- ● Other FODMAPs (cumulative fermentation may worsen symptoms in sensitive individuals)
일일 최대 섭취 허용량: Well-tolerated up to 20 g/day; start low and increase gradually
건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
Frequently Asked Questions
Does Inulin help with Gut Dysbiosis?
Based on 3 studies with 200 participants, there is preliminary evidence that needs more research that Inulin may support Gut Dysbiosis management. Our evidence grade is D (Very Early Research).
How much Inulin should I take for Gut Dysbiosis?
Studies have used various dosages. A commonly studied range is 5-10 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Inulin?
Reported side effects may include Gas and bloating (common at higher doses; start with 3-5 g/day and titrate up), Abdominal cramping, Flatulence, Loose stools at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Inulin and Gut Dysbiosis?
We rate the evidence as Grade D (Very Early Research). This rating is based on 3 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.
Related Evidence
관련 다른 성분: Gut Dysbiosis
Inulin 다른 건강 상태에 대한 근거
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.